Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors

Journal of the American College of Cardiology

Volumn 67, Issue 8, 2016, Pages 921-931

  Puricel, Serban ^a   Cuculi, Florim ^b   Weissner, Melissa ^c,d   Schmermund, Axel ^e   Jamshidi, Peiman ^b   Nyffenegger, Tobias ^b   Binder, Harald ^c   Eggebrecht, Holger ^e   Münzel, Thomas ^c,d   Cook, Stephane ^a   Gori, Tommaso ^c,d  

^a University and Hospital Fribourg ^*  (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^e CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

Author keywords

bioresorbable scaffold; stent thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BIORESORBABLE VASCULAR STENT; BLOOD VESSEL DIAMETER; BLOOD VESSEL PARAMETERS; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERMANY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); POST PROCEDURAL MINIMUM LUMEN DIAMETER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTHESIS IMPLANTATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SUDDEN CARDIAC DEATH; SWISS; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SWITZERLAND; TIME FACTOR; TISSUE SCAFFOLD; TRENDS;

ABSORBABLE IMPLANTS; ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; GERMANY; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SURVIVAL RATE; SWITZERLAND; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 84959019978     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.12.019     Document Type: Article

References (27)

1. P.W. Serruys, H.M. Garcia-Garcia, and Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 2012 16 25b
2. P.W. Serruys, Y. Onuma, D. Dudek, and et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
3. R. Diletti, V. Farooq, C. Girasis, and et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of Absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial Heart 99 2013 98 105
4. P.W. Serruys, B. Chevalier, D. Dudek, and et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
5. S.G. Ellis, D.J. Kereiakes, D.C. Metzger, and et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease N Engl J Med 373 2015 1905 1915
6. S. Puricel, D. Arroyo, N. Corpataux, and et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds J Am Coll Cardiol 65 2015 791 801
7. D. Capodanno, T. Gori, H. Nef, and et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry EuroIntervention 10 2015 1144 1153
8. R.P. Kraak, M.E. Hassell, M.J. Grundeken, and et al. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry EuroIntervention 10 2015 1160 1168
9. A. Ielasi, B. Cortese, A. Varricchio, and et al. Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry) EuroIntervention 11 2015 157 162
10. T. Gori, E. Schulz, U. Hink, and et al. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes EuroIntervention 9 2014 1036 1041
11. S. Cassese, R.A. Byrne, G. Ndrepepa, and et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials Lancet 2015 Nov 16 [E-pub ahead of print]
12. S. Brugaletta, T. Gori, A.F. Low, and et al. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study J Am Coll Cardiol Intv 8 2015 189 197
13. C. Tamburino, A. Latib, R.J. van Geuns, and et al. Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective EuroIntervention 11 2015 45 52
14. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. T. Gori, E. Schulz, U. Hink, and et al. Clinical, angiographic, functional, and imaging outcomes 12 months after implantation of drug-eluting bioresorbable vascular scaffolds in acute coronary syndromes J Am Coll Cardiol Intv 8 2015 770 777
16. H.M. Garcia-Garcia, P.W. Serruys, C.M. Campos, and et al. Assessing bioresorbable coronary devices: methods and parameters J Am Coll Cardiol Img 7 2014 1130 1148
17. T. Pilgrim, D. Heg, M. Roffi, and et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial Lancet 384 2014 2111 2122
18. C. von Birgelen, H. Sen, M.K. Lam, and et al. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial Lancet 383 2014 413 423
19. N. van Boven, S. Windecker, V.A. Umans, and et al. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF Heart 101 2015 50 57
20. M. Mutoh, T. Ishikawa, T. Hasuda, and et al. Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation: retrospective analysis in consecutive 1,070 angiographic follow-up lesions Circ J 71 2007 1328 1331
21. F. D'Ascenzo, M. Bollati, F. Clementi, and et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses Int J Cardiol 167 2013 575 584
22. T. Gori, J. Wiebe, D. Capodanno, and et al. Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry EuroIntervention 2015 Sep 8 [E-pub ahead of print]
23. D.R. Holmes Jr., D.J. Kereiakes, S. Garg, and et al. Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
24. U.K. Allahwala, J.A. Cockburn, E. Shaw, G.A. Figtree, P.S. Hansen, and R. Bhindi Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention EuroIntervention 10 2015 1154 1159
25. T. Gori, E. Schulz, and T. Munzel Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds J Am Coll Cardiol Intv 7 2014 1194 1195
26. A. Karanasos, N. Van Mieghem, N. van Ditzhuijzen, and et al. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience Circ Cardiovasc Interv 8 2015 e002369
27. A. Mattesini, G.G. Secco, G. Dall'Ara, and et al. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance J Am Coll Cardiol Intv 7 2014 741 750